Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Harrow Health Inc.

    NASDAQ: HROW · Real-Time Price · USD
    31.53
    1.22 (4.03%)
    At close: Jun 16, 2025, 3:59 PM
    31.60
    0.22%
    Pre-market: Jun 17, 2025, 08:11 AM EDT

    Harrow Health Statistics

    Share Statistics

    Harrow Health has 36.7M shares outstanding. The number of shares has increased by 0.66% in one year.

    Shares Outstanding

    n/a
    		 36.7M

    Shares Change (YoY)

    n/a
    		 0.66%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 58.36%

    Shares Floating

    n/a
    		 30.83M

    Failed to Deliver (FTD) Shares

    n/a
    		 65

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 4.21M, so 11.47% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.21M

    Short % of Shares Out

    n/a
    		 11.47%

    Short % of Float

    n/a
    		 14.49%

    Short Ratio (days to cover)

    n/a
    		 10.23

    Valuation Ratios

    The PE ratio is -68.42 and the forward PE ratio is 20.11. Harrow Health's PEG ratio is 1.97.

    PE Ratio

    n/a
    		 -68.42

    Forward PE

    n/a
    		 20.11

    PS Ratio

    n/a
    		 5.99

    Forward PS

    n/a
    		 2

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -19.65

    PEG Ratio

    n/a
    		 1.97
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Harrow Health.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    Current Ratio

    n/a
    		 0

    Quick Ratio

    n/a
    		 0

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 11.44

    Debt / FCF

    n/a
    		 -3.76

    Interest Coverage

    n/a
    		 0.39

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $522,549.74

    Profits Per Employee

    n/a
    		 $-45,761.78

    Employee Count

    n/a
    		 382

    Asset Turnover

    n/a
    		 0.51

    Inventory Turnover

    n/a
    		 4.6

    Taxes

    Income Tax

    n/a
    		 -161B

    Effective Tax Rate

    n/a
    		 892362.27%

    Stock Price Statistics

    The stock price has increased by 78.24% in the last 52 weeks. The beta is 0.4, so Harrow Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.4

    52-Week Price Change

    n/a
    		 78.24%

    50-Day Moving Average

    n/a
    		 26.22

    200-Day Moving Average

    n/a
    		 34.96

    Relative Strength Index (RSI)

    n/a
    		 64.37

    Average Volume (20 Days)

    n/a
    		 555,344

    Income Statement

    In the last 12 months, Harrow Health had revenue of 199.61M and earned -17.48M in profits. Earnings per share was -0.49.

    Revenue

    n/a
    		 199.61M

    Gross Profit

    n/a
    		 150.37M

    Operating Income

    n/a
    		 8.82M

    Net Income

    n/a
    		 -17.48M

    EBITDA

    n/a
    		 20M

    EBIT

    n/a
    		 4.74M

    Earnings Per Share (EPS)

    n/a
    		 -0.49
    Full Income Statement

    Balance Sheet

    The company has 47.25M in cash and 228.83M in debt, giving a net cash position of -181.58M.

    Cash & Cash Equivalents

    n/a
    		 47.25M

    Total Debt

    n/a
    		 228.83M

    Net Cash

    n/a
    		 -181.58M

    Retained Earnings

    n/a
    		 -151,385B

    Total Assets

    n/a
    		 364.16M

    Working Capital

    n/a
    		 -17.45M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -22.2M and capital expenditures -38.67M, giving a free cash flow of -60.88M.

    Operating Cash Flow

    n/a
    		 -22.2M

    Capital Expenditures

    n/a
    		 -38.67M

    Free Cash Flow

    n/a
    		 -60.88M

    FCF Per Share

    n/a
    		 -1.71
    Full Cash Flow Statement

    Margins

    Gross margin is 75.33%, with operating and profit margins of 4.42% and -8.76%.

    Gross Margin

    n/a
    		 75.33%

    Operating Margin

    n/a
    		 4.42%

    Pretax Margin

    n/a
    		 -9.04%

    Profit Margin

    n/a
    		 -8.76%

    EBITDA Margin

    n/a
    		 9.66%

    EBIT Margin

    n/a
    		 4.42%

    FCF Margin

    n/a
    		 -30.5%

    Dividends & Yields

    HROW does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for HROW is $62.5, which is 98.2% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $62.5

    Price Target Difference

    n/a
    		 98.2%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 8, 2013. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Feb 8, 2013

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 1.75

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist